Compare COO & BWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | BWA |
|---|---|---|
| Founded | 1980 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.6B |
| IPO Year | 1994 | 1995 |
| Metric | COO | BWA |
|---|---|---|
| Price | $70.23 | $64.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $90.18 | $59.33 |
| AVG Volume (30 Days) | ★ 2.7M | 2.4M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.27 | ★ 1.16 |
| Revenue | $2,532,800,000.00 | ★ $14,316,000,000.00 |
| Revenue This Year | $6.66 | $1.54 |
| Revenue Next Year | $5.18 | $3.54 |
| P/E Ratio | $254.56 | ★ $55.06 |
| Revenue Growth | ★ 18.41 | 1.63 |
| 52 Week Low | $58.89 | $34.27 |
| 52 Week High | $89.83 | $78.82 |
| Indicator | COO | BWA |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 42.35 |
| Support Level | $67.91 | $62.40 |
| Resistance Level | $73.21 | $70.19 |
| Average True Range (ATR) | 1.96 | 1.90 |
| MACD | -0.36 | -0.45 |
| Stochastic Oscillator | 31.91 | 23.46 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.